QR Code

Combination Therapy of RAS Inhibition and SGLT2 Inhibitors Decreases Levels of Endotrophin in Persons with Type 2 Diabetes

We investigated for the first time the effect of combination therapy of renin–angiotensin system inhibition (RASi) and sodium–glucose co-transporter-2 inhibitors (SGLT2is) on endotrophin (ETP), a pro-fibrotic signaling molecule reflecting collagen type VI formation, measured in the plasma of persons...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Alexandra Louise Møller, Stefanie Thöni, Felix Keller, Samir Sharifli, Daniel Guldager Kring Rasmussen, Federica Genovese, Morten Asser Karsdal, Gert Mayer
Hōputu: Artigo
Reo:Inglês
I whakaputaina: MDPI AG 2023-11-01
Rangatū:Biomedicines
Ngā marau:
diabetic kidney disease
biomarker
fibrosis
extracellular matrix
collagen
endotrophin
Urunga tuihono:https://www.mdpi.com/2227-9059/11/11/3084
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite